Christopher Pierce

Insider Reports History

Entity
Individual
Location
C/O Prelude Therapeutics Incorporated, 200 Powder Mill Road, Wilmington, DE
Signature
/s/ Brian Piper, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Pierce:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Prelude Therapeutics Inc EVP and Chief of Business Oper Common Stock 3.75K $14.1K $3.77 Sep 2, 2021 Direct
Prelude Therapeutics Inc EVP and Chief of Business Oper Employee Stock Option (right to buy) 208K Sep 2, 2021 Direct

Insider Reports Filed by Christopher Pierce

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRLD Prelude Therapeutics Inc Sep 2, 2021 5 -$490K 4 Sep 7, 2021 EVP and Chief of Business Oper
PRLD Prelude Therapeutics Inc Jul 20, 2021 1 $0 4 Jul 22, 2021 EVP and Chief of Business Oper